Serum hepatitis B surface antigen quantitation can reflect hepatitis B virus in the liver and predict treatment response.
about
HBV induced HCC: major risk factors from genetic to molecular levelRapid and quantitative detection of hepatitis B virusDiagnosis of hepatitis BHBsAg level and clinical course in patients with chronic hepatitis B treated with nucleoside analogue: five years of follow-up data.Recent data on treatment of chronic hepatitis B with nucleos(t)ide analogues.Optimization therapy for the treatment of chronic hepatitis BIncidence and predictors of HBV relapse after cessation of nucleoside analogues in HBeAg-negative patients with HBsAg ≤ 200 IU/mL.Quantitative measurement of serum hepatitis B surface antigen using an immunoradiometric assay in chronic hepatitis BChronic hepatitis B: whom to treat and for how long? Propositions, challenges, and future directions.Baseline value of intrahepatic HBV DNA over cccDNA predicts patient's response to interferon therapyClinical utility of hepatitis B surface antigen levels during the natural history and treatment of chronic hepatitis B infectionHepatitis B surface antigen levels during natural history of chronic hepatitis B: a Chinese perspective studyThe G1613A mutation in the HBV genome affects HBeAg expression and viral replication through altered core promoter activityComparison of serum HBsAg quantitation by four immunoassays, and relationships of HBsAg level with HBV replication and HBV genotypes.Persistence of hepatitis B virus covalently closed circular DNA in hepatocytes: molecular mechanisms and clinical significance.Strategies to eliminate HBV infection.Hepatitis B surface antigen levels at 6 months after treatment can predict the efficacy of lamivudine-adefovir combination therapy in patients with lamivudine-resistant chronic hepatitis B.Comparison of three luminescent immunoassays for hepatitis B virus surface antigen quantification during the natural history of chronic hepatitis B virus infection.Mutations of pre-core and basal core promoter before and after hepatitis B e antigen seroconversionAnalysis of hepatitis B virus intrahepatic covalently closed circular DNA and serum viral markers in treatment-naive patients with acute and chronic HBV infection.Serum hepatitis B surface antigen titer and transient elastography in screening for insignificant fibrosis in HBeAg-positive chronic hepatitis B patients.Evaluation of changes of serum hepatitis B surface antigen from a different perspective.Short-term spontaneous fluctuations of HBV DNA levels in a Senegalese population with chronic hepatitis B.Serodiagnosis for tumor viruses.Correlation between HBsAg quantitative assay results and HBV DNA levels in chronic HBV.Efficacy of tenofovir disoproxil fumarate therapy in nucleoside-analogue naive Iranian patients treated for chronic hepatitis B.Response-guided therapy of regimens based on PEG-interferon for chronic hepatitis B using on-treatment hepatitis B surface antigen quantification: a meta-analysis.Predictors of sustained virologic response after discontinuation of nucleos(t)ide analog treatment for chronic hepatitis B.Hepatitis B Surface Antigen Quantification across Different Phases of Chronic Hepatitis B Virus Infection Using an Immunoradiometric AssayFactors Predicting HBsAg Seroclearance and Alanine Transaminase Elevation in HBeAg-Negative Hepatitis B Virus-Infected Patients with Persistently Normal Liver Function.Elecsys hepatitis B surface antigen quantitative assay: performance evaluation and correlation with hepatitis B virus DNA during 96 weeks of follow-up in chronic hepatitis B patients.Hepatitis B and D viruses replication interference: Influence of hepatitis B genotype.Dynamic Characteristics of Serum Hepatitis B Surface Antigen in Chinese Chronic Hepatitis B Patients Receiving 7 Years of Entecavir Therapy.Hepatitis B surface antigen clearance in inactive hepatitis B surface antigen carriers treated with peginterferon alfa-2aVirus and Host Testing to Manage Chronic Hepatitis B.Analysis of baseline hepatitis B virus DNA levels in chronic hepatitis B patients with non-hematological malignancies prior to the initiation of cancer chemotherapy.Monitoring during and after antiviral therapy for hepatitis B.Hepatitis B surface antigen titer is a good indicator of durable viral response after entecavir off-treatment for chronic hepatitis B.Diagnosis of hepatitis B virus infection through serological and virological markers.Spontaneous resolution of de novo hepatitis B after living donor liver transplantation with hepatitis B core antibody positive graft: a case report.
P2860
Q26825274-60720AC5-9F10-4E24-B21D-21282F951703Q26852749-94E732FC-EF73-4B98-B9DC-F340B4846B5FQ28071817-D1B1D88E-F2CD-4991-BE7B-EFFC6943FB51Q30741676-8892B628-6E72-4C80-AA6E-A4BC29BE21A1Q33492413-700CFB0D-202F-47D0-991C-378008A16876Q33626813-9C3DC082-1359-488D-907B-23177DCB4F3EQ33686951-4B7ACFCD-EABA-47A2-95FD-832D19C5A501Q33704165-EA900598-7F9B-4C3E-88B6-EAE95867779FQ33718958-FB82EE62-0163-4739-B7AE-A7D72427CD76Q33918392-106C5895-D264-4475-8175-03E1426E570CQ33947471-B9978484-103D-45A6-BD41-BBD83FF350EBQ33958876-B058F0F2-8614-4237-9847-134FAB64741BQ33981411-3987A818-59EE-462B-86EE-10B469B7D811Q34189348-7BF33E03-71D6-4AFB-987C-42C68BA5FCA0Q34289969-F829912B-D20B-4150-BB19-40B1BF31EBF2Q34308129-06D90935-6E9E-4804-A5CE-7BC2A73EDBDCQ34339613-ADD03B43-545F-49C6-BDEB-9FFE1E441507Q34592952-A7E5050B-B183-4FBF-935C-BC1ACBE1B788Q34932600-32582FB5-743A-4F47-A33C-9F6FD8FE4441Q35097694-6ED3CD08-F597-4377-AD89-0E1A3F0ABC8FQ35105157-802DC0CC-2DAB-404E-9DB0-2EE33C7D5731Q35152364-3136469C-8D32-4967-A6A2-D701D1CB39FBQ35224148-0955280B-12F6-4A29-BC5B-4D072BC6855BQ35289576-5AFEE99A-5D7D-43CC-BA38-D3A80EB9EF75Q35540204-06430EA1-DEB4-4338-939B-4CC64528E41BQ35671645-B1D81494-86BF-404B-91B1-8D1F76BE6773Q35688409-3068B3EB-C1F7-4A2F-8835-54BB4E569155Q35973806-EDE5BCCE-5E4D-447F-BA20-A14605FE0415Q36037164-ADB3BE69-A9B9-4F68-8826-11251BDD72C0Q36217581-C8EFD5E7-8888-4A1B-9AD4-8573A6A92604Q36365030-8AE96F92-47A0-4E2A-B8EC-8C9CD46CA88DQ36682594-CB90F9FB-BE1E-430A-A9C7-338F3DD8622BQ36797804-8B382AE1-25AF-45AC-B21B-7F699DCCF927Q36924978-D5B6D087-44F8-49A3-B5EF-F461034C82B6Q36958940-D0A43632-570E-4C68-B20B-F361B9F388ECQ37001173-38E9499F-A271-4464-9105-4DB3C8AEC0F2Q37186162-746D54BA-58C2-4C6E-A061-D4B41360184CQ37343296-3413FF16-8825-4AAD-9EA6-C3EC0824D166Q37345962-7C69823C-993D-4484-8062-B3DD86B87DAEQ37372998-058EEA4D-ABBB-4389-AB2C-79C7C136B860
P2860
Serum hepatitis B surface antigen quantitation can reflect hepatitis B virus in the liver and predict treatment response.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Serum hepatitis B surface anti ...... nd predict treatment response.
@en
Serum hepatitis B surface anti ...... nd predict treatment response.
@nl
type
label
Serum hepatitis B surface anti ...... nd predict treatment response.
@en
Serum hepatitis B surface anti ...... nd predict treatment response.
@nl
prefLabel
Serum hepatitis B surface anti ...... nd predict treatment response.
@en
Serum hepatitis B surface anti ...... nd predict treatment response.
@nl
P2093
P1476
Serum hepatitis B surface anti ...... and predict treatment response
@en
P2093
Ada Mei-Ling Tse
Angel Mei-Ling Chim
Chi-Hang Tse
Grace Lai-Hung Wong
Henry Lik-Yuen Chan
Hoi-Yun Chan
Vincent Wai-Sun Wong
P304
P356
10.1016/J.CGH.2007.09.005
P407
P577
2007-12-01T00:00:00Z